Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

Clinical trial NCT06765161 · RECRUITING

Trial details

NCT number: NCT06765161
Sponsor: Clinique Neuro-Outaouais
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthaenia Gravis

Start date: 2025-02-06
Primary completion: 2027-01-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.